Yale jf
Yale jf
Verified email at mcgill.ca - Homepage
Cited by
Cited by
Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial
DREAM (Diabetes REduction Assessment with ramipril and rosiglitazone ...
The Lancet 368 (9541), 1096-1105, 2006
1998 clinical practice guidelines for the management of diabetes in Canada. Canadian Diabetes Association.
S Meltzer, L Leiter, D Daneman, HC Gerstein, D Lau, S Ludwig, JF Yale, ...
CMAJ: Canadian Medical Association journal= journal de l'Associationá…, 1998
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 121-130, 2019
Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease
JF Yale, G Bakris, B Cariou, D Yue, E David‐Neto, L Xi, K Figueroa, ...
Diabetes, Obesity and Metabolism 15 (5), 463-473, 2013
Pragmatic adjudication
RA Posner
Cardozo L. Rev. 18, 1, 1996
Impact of a computer-based patient record system on data collection, knowledge organization, and reasoning
VL Patel, AW Kushniruk, S Yang, JF Yale
Journal of the American Medical Informatics Association 7 (6), 569-585, 2000
Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management
LA Leiter, JF Yale, JL Chiasson, S Harris, P Kleinstiver, L Sauriol
Can J Diabetes 29 (3), 186-192, 2005
Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial
JS Skyler, RS Weinstock, P Raskin, JF Yale, E Barrett, JE Gerich, ...
Diabetes care 28 (7), 1630-1635, 2005
A randomized trial of adding insulin glargine vs. avoidance of insulin in people with type 2 diabetes on either no oral glucose‐lowering agents or submaximal doses of metforminá…
HC Gerstein, JF Yale, SB Harris, M Issa, JA Stewart, E Dempsey
Diabetic Medicine 23 (7), 736-742, 2006
Efficacy and safety of canagliflozin over 52 weeks in patients with type 2 diabetes mellitus and chronic kidney disease
JF Yale, G Bakris, B Cariou, J Nieto, E David‐Neto, D Yue, E Wajs, ...
Diabetes, Obesity and Metabolism 16 (10), 1016-1027, 2014
Pharmacologic management of type 2 diabetes
W Harper, M Clement, R Goldenberg, A Hanna, A Main, R Retnakaran, ...
Canadian Journal of Diabetes 37, S61-S68, 2013
Effect of acarbose on insulin sensitivity in elderly patients with diabetes.
GS Meneilly, EA Ryan, J Radziuk, DC Lau, JF Yale, J Morais, ...
Diabetes care 23 (8), 1162-1167, 2000
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
HC Gerstein, HM Colhoun, GR Dagenais, R Diaz, M Lakshmanan, P Pais, ...
The Lancet 394 (10193), 131-138, 2019
Chronic kidney disease and intensive glycemic control increase cardiovascular risk in patients with type 2 diabetes
V Papademetriou, L Lovato, M Doumas, E Nylen, A Mottl, RM Cohen, ...
Kidney international 87 (3), 649-659, 2015
Associations between ambient air pollution and daily mortality among persons with diabetes and cardiovascular disease
MS Goldberg, RT Burnett, JF Yale, MF Valois, JR Brook
Environmental research 100 (2), 255-267, 2006
Type 2 diabetes mellitus management in Canada: is it improving?
LA Leiter, L Berard, CK Bowering, AY Cheng, KG Dawson, JM EkoÚ, ...
Canadian journal of diabetes 37 (2), 82-89, 2013
Peroxovanadium compounds: biological actions and mechanism of insulin-mimesis
AP Bevan, PG Drake, JF Yale, A Shaver, BI Posner
Vanadium Compounds: Biochemical and Therapeutic Applications, 49-58, 1995
SGLT2 inhibitor–associated diabetic ketoacidosis: clinical review and recommendations for prevention and diagnosis
RM Goldenberg, LD Berard, AYY Cheng, JD Gilbert, S Verma, VC Woo, ...
Clinical Therapeutics 38 (12), 2654-2664. e1, 2016
Problems in transition from pediatric care to adult care for individuals with diabetes
D Pacaud, JF Yale, D Stephure, R Trussell, HD Davies
Canadian Journal of Diabetes 29 (1), 13-18, 2005
The effect of a thiazolidinedione drug, troglitazone, on glycemia in patients with type 2 diabetes mellitus poorly controlled with sulfonylurea and metformin: a multicenterá…
JF Yale, TR Valiquett, MN Ghazzi, JK Owens-Grillo, RW Whitcomb, ...
Annals of internal medicine 134 (9_Part_1), 737-745, 2001
The system can't perform the operation now. Try again later.
Articles 1–20